Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The Narrative About Gold is Changing Again

Teaser: Let’s face it, we live in a world of radical uncertainty. Yet we’re supposed to make perfectly rational decisions – so, how do we cope with the unknown? We tell narratives, and form our decisions around them! Let’s...

Biotech to Test Stem Cell Product in COVID-19-Caused Acute Respiratory Distress

A description of Mesoblast's multi-site clinical trial and possible implication for the therapeutic are provided in an H.C. Wainwright & Co. report. In an April 9 research note, H.C. Wainwright & Co. analyst Swayampakula Ramakanth reported that Mesoblast Lt...

Biopharma's Brain Cancer Therapeutic Compelling, Its Stock Undervalued

A description of the asset and its potential are provided in a Dawson James report. In a July 11 research note, Dawson James Securities analyst Jason Kolbert reported that coverage of DelMar Pharmaceuticals Inc. (DMPI:NASDAQ) transferred to him and, subseq...

The Powerful 2008 Lessons That Apply to Gold Today

Mark Twain said that history does not repeat itself, but it rhymes. It’s certainly true in both life and financial markets. Let’s explore how the recent history lessons apply to the precious metals. The 2008 - Now Link Let&CloseCurlyQuot...

Biotech to Test Stem Cell Product in COVID-19-Caused Acute Respiratory Distress

A description of Mesoblast's multi-site clinical trial and possible implication for the therapeutic are provided in an H.C. Wainwright & Co. report.

Guyana Goldstrike aims to add ounces at gold-bearing iron formation

Wedged between two resource giants on the north coast of South America, Guyana has a low profile among its more well-known neighbors: Venezuela to the west and the dense rainforests of Brazil’s Amazon region to the south. The Caribbean nation bordering the ...

dynaCERT, McPhy, SolGold - the right shares for the future

Scalability is usually a key feature for success stories. As soon as the preliminary work or development is completed, the money-making process begins. Patents can also be equivalent to a license to print money. In addition to the technology industry, the description also appl...

Trillion Energy (CSE:TCF) announces substantial 2022 year-end reserves report

Trillion Energy (TCF) has shared its third-party December 31, 2022 year-end reserves report Net present value of proved and probable (P2) natural gas reserves (NPV10%) increased to US$432 million net to Trillion, up from US$82 million (2021), a 426-per-cent ...

Cannabis Firm's Stock Poised for 'Substantial Gains'

Technical analyst Clive Maund charts how news from this company affects its investment thesis. The reason for this brief update is that this is a good juncture to bring to your attention that the technical condition of Captiva Verde's stock continues to improve, to the ...

Target Price Raised on Metals Firm 'Growing Substantial High-Grade Project'

The newly announced resource update and what it means in terms of project economics is captured in a ROTH Capital Partners report. In a March 18 research note, analyst Jake Sekelsky reported that ROTH Capital Partners raised its target price on Buy-rated SilverCrest Me...
1 2 3 4 5 6 7 8 9 10 ...